PatternsRadar
Sign in

INDRAMEDCOIndraprastha Medical Corporation Limited

NSE
362.60INR+2.25 (+0.62%)Close · 20 Nov 2026
29 Oct 2026Last results
HealthcareSector
Healthcare ServicesIndustry
₹3,324 CrMarket cap
17.3P/E (TTM)
40.7%Delivery

Filings & corporate actions

79 results filed
CSV
Next results · Q3 FY27
Expected 3 Feb 2027 – 9 Feb 2027
Estimate: filed 34–40 days after quarter end, last 5 times
Dividend
₹4.00 per share · last 18 Sept 2026
2026
  • 29 OctresultsResults · Q2 FY27 · standalone-4.0%NSE
  • 12 OctshareholdingShareholding · 30 Sept 2026+0.7%NSE
  • 18 SeptdividendDividend · ₹4.00 per share · record 18 Sept 2026-0.2%
  • 6 AugresultsResults · Q1 FY27 · standalone+5.2%NSE
  • 15 JulshareholdingShareholding · 30 Jun 2026+0.8%NSE
  • 12 MayresultsResults · Q4 FY26 · standalone-5.2%NSE
  • 8 AprshareholdingShareholding · 31 Mar 2026+2.8%NSE
  • 3 FebresultsResults · Q3 FY26 · standalone-1.7%NSE
  • 13 JanshareholdingShareholding · 31 Dec 2025-1.2%NSE

Reaction to results · all yearsrose on day 0 in 36 of 78 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2729 Oct 2026-4.0%+3.7%—0.6×
Q1 FY276 Aug 2026+5.2%+3.2%-3.4%65.3×
Q4 FY2612 May 2026-5.2%-13.5%-9.4%1.2×
Q3 FY263 Feb 2026-1.7%+8.0%+0.9%1.8×
Q2 FY261 Nov 2025-5.2%-9.1%-17.6%1.3×
Q1 FY266 Aug 2025+3.8%+2.6%+7.2%10.5×
Q4 FY2516 May 2025-1.9%-0.9%-6.8%2.6×
Q3 FY253 Feb 2025-2.1%-5.9%-26.2%2.1×
Q2 FY2530 Oct 2024-6.1%+6.6%+9.0%1.8×
Q1 FY255 Aug 2024+19.8%+21.9%+73.7%16.0×
Q4 FY2417 May 2024-0.6%-8.5%-2.8%0.2×
Q3 FY246 Feb 2024+1.2%+1.7%-7.1%1.8×
Q2 FY243 Nov 2023+5.0%+18.6%+17.7%2.8×
Q1 FY244 Aug 2023+5.0%+16.6%+27.1%0.5×
Q4 FY2323 May 2023+0.6%+5.8%+11.3%1.9×
Q3 FY238 Feb 2023+1.9%+0.7%-0.4%0.6×
Q2 FY235 Nov 2022+12.4%+21.1%+14.7%20.2×
Q1 FY239 Aug 2022+3.4%+6.8%+15.8%3.4×
Q4 FY2223 May 2022+2.4%+2.6%-10.4%1.3×
Q3 FY229 Feb 2022+0.7%-5.2%-15.7%0.5×
Q2 FY2210 Nov 2021+2.2%+5.1%+2.7%4.9×
Q1 FY2210 Aug 2021+0.3%+2.1%-1.1%3.0×
Q4 FY2110 Jun 2021-3.2%-9.2%-16.6%1.0×
Q3 FY219 Feb 2021-2.0%-1.9%-0.7%0.6×
Q2 FY2111 Nov 20200.0%+4.8%+25.5%1.1×
Q1 FY2125 Aug 2020-7.4%-13.5%-18.9%1.2×
Q4 FY2023 May 2020-2.4%+11.7%+65.7%0.6×
Q3 FY204 Feb 2020+3.9%-1.1%-10.4%0.5×
Q2 FY205 Nov 2019-2.1%-1.4%-5.5%11.9×
Q1 FY2026 Jul 2019+4.7%0.0%+1.9%3.4×
Q4 FY1924 May 2019+2.2%+1.9%-4.1%3.2×
Q3 FY191 Feb 2019-2.8%-3.9%+1.6%0.9×
Q2 FY1921 Nov 2018-0.4%-1.5%-3.0%0.4×
Q1 FY193 Aug 2018+1.1%+0.8%+8.6%0.9×
Q4 FY188 Jun 2018+0.3%+1.4%-2.8%0.7×
Q3 FY1828 Feb 2018-1.4%-5.9%-6.8%0.6×
Q2 FY1822 Nov 2017+0.7%+2.6%+3.9%0.6×
Q1 FY181 Aug 2017-0.4%-5.1%-4.8%1.6×
Q4 FY1731 May 2017+2.2%+4.3%-0.7%0.8×
Q3 FY1731 Jan 2017+0.2%+2.1%-1.4%2.1×
Q2 FY1724 Nov 2016-1.5%-0.6%-1.3%0.4×
Q1 FY173 Oct 2016+0.2%+4.6%+15.3%0.9×
Q4 FY1626 May 2016-0.2%-0.2%-2.0%0.6×
Q3 FY1615 Feb 2016-2.9%-1.7%-3.5%0.5×
Q2 FY164 Nov 2015-1.4%-3.3%+9.0%0.4×
Q1 FY168 Aug 2015-5.5%-8.3%-18.0%0.8×
Q4 FY1529 May 2015+0.6%-5.4%-3.1%0.3×
Q3 FY1530 Jan 2015+0.1%-10.4%-7.3%0.1×
Q2 FY1512 Nov 2014-2.0%-2.5%+8.8%1.2×
Q1 FY1530 Jul 2014-1.2%-1.2%+7.4%0.5×
Q4 FY1426 May 2014-7.6%-5.7%+2.6%3.3×
Q3 FY1430 Jan 2014-1.6%-1.3%+1.0%0.7×
Q2 FY1415 Nov 2013-2.8%-1.5%-4.8%0.8×
Q1 FY141 Aug 2013+0.2%-0.2%-0.6%0.5×
Q4 FY1317 May 2013+8.0%-1.4%-6.7%11.2×
Q3 FY1322 Feb 2013-1.1%-3.4%-7.3%5.5×
Q2 FY132 Nov 2012+1.9%+9.5%+12.5%0.7×
Q1 FY132 Aug 2012+1.9%+1.9%+3.6%2.4×
Q3 FY1215 Feb 2012-3.1%-5.5%-4.6%1.4×
Q2 FY1214 Nov 2011-0.1%-5.1%0.0%0.4×
Q1 FY121 Aug 2011+0.7%-5.3%-5.3%0.2×
Q4 FY1112 May 2011+0.3%-3.2%+1.4%0.9×
Q3 FY119 Feb 2011-6.8%+1.7%-1.3%3.9×
Q2 FY113 Nov 2010-1.0%+2.0%-8.3%0.7×
Q1 FY1128 Jul 2010-0.8%-1.3%+0.3%1.5×
Q4 FY1027 Apr 2010-2.2%-4.9%-14.3%0.8×
Q3 FY1023 Jan 2010-1.3%-1.9%-9.2%0.3×
Q2 FY1021 Oct 2009+3.5%-2.6%+5.2%6.1×
Q1 FY1028 Jul 2009+1.1%-0.7%+8.7%4.0×
Q4 FY0930 Apr 2009+2.3%+7.7%+25.8%0.5×
Q3 FY0923 Jan 2009+0.6%0.0%+1.5%2.7×
Q2 FY0922 Oct 2008-1.4%-0.7%+14.9%0.3×
Q1 FY0929 Jul 2008-0.2%+11.9%+8.8%0.6×
Q4 FY089 Jun 2008-0.2%+3.4%-7.5%0.7×
Q3 FY0829 Jan 2008-4.3%-6.2%-10.7%0.3×
Q2 FY0812 Oct 2007-1.9%-7.6%-11.4%0.4×
Q1 FY0826 Jul 2007-2.4%-4.8%+0.3%0.8×
Q4 FY0730 May 2007+5.2%+3.5%+0.8%7.2×
Average+0.0%+0.3%+1.4%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+8.4%
Profit YoY+8.3%
Interest cost YoY+2.0%
Revenue QoQ+1.6%
Profit QoQ-4.1%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+8.6%+9.8%+11.7%+13.8%+15.8%+9.6%
Profit+14.0%+22.7%+25.9%+28.6%—+24.8%

Key data

Open360.00
Day range358.00 – 369.00
52-week range293.65 – 553.15
From 52w high-34.4%
RSI (14)66.3
ATR (14)11.96
Volume2.11L
Avg volume (20D)4.14L
Rel volume0.51×
Volatility (1Y)35.9%
Turnover₹7.7Cr
Traded value (NSE)₹7.7Cr
VWAP364.75
SMA 50 / 200338.02 / 375.69
Price band20%

Delivery percentage

Latest · 20 Nov 202640.7%
20-day avg52.1%
1-year avg54.9%
Percentile (own history)8th
Range7.8–100.0%
Sessions3,629

Over the last 20 sessions INDRAMEDCO settled 52.1% of its traded quantity, which is above average for an NSE equity. Its one-year average is 54.9%, so recent sessions are running 2.8 points lower than usual. The latest session ranks higher than 8% of the 3,629 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield1.10%
Dividend, trailing 12M₹4.00
Paid every year for5 yr
Shareholders77.7K · +3.5% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy408 days ago

Performance returns

1D1W1M3M6M1Y
Price+0.62%+9.83%+18.65%-3.77%+2.01%-33.85%

Valuation

Market cap₹3,324 Cr
Market cap (NSE)₹3,324 Cr
Free-float cap₹1,629 Cr
P/E (TTM)17.3
P/E (NSE)17.2
EPS (TTM)20.96
P/B4.1
Net margin (TTM)12.4%
Other income / PBT12.2%
ROE26.1%
Debt / equity0.00
Shares outstanding9.17Cr
Listed17 Apr 1997

Ownership

Promoter51.00%
Promoter Δ QoQ0.00 pp
Public49.00%
FII2.39%
DII1.77%
Pledged0.00%

Quarterly results · standalone

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)371.6364.8406.2412.9
YoY chg+14.4%+9.3%+11.3%+8.4%
Net profit (₹ Cr)41.041.755.953.6
YoY chg+25.0%+1.7%+8.5%+8.3%
Net margin11.0%11.4%13.8%13.0%
EPS4.474.550.005.84

Shareholding over time

By quarter

30 Sept 2026 · promoter 51.00% · public 49.00%
31 Mar 2021: promoter 51.00%30 Sept 2021: promoter 51.00%31 Dec 2021: promoter 51.00%31 Mar 2022: promoter 51.00%30 Jun 2022: promoter 51.00%30 Sept 2022: promoter 51.00%31 Dec 2022: promoter 51.00%31 Mar 2023: promoter 51.00%30 Jun 2023: promoter 51.00%30 Sept 2023: promoter 51.00%31 Dec 2023: promoter 51.00%31 Mar 2024: promoter 51.00%30 Jun 2024: promoter 51.00%30 Sept 2024: promoter 51.00%31 Dec 2024: promoter 51.00%31 Mar 2025: promoter 51.00%30 Jun 2025: promoter 51.00%30 Sept 2025: promoter 51.00%31 Dec 2025: promoter 51.00%31 Mar 2026: promoter 51.00%30 Jun 2026: promoter 51.00%30 Sept 2026: promoter 51.00%
2021-032026-09
  • Promoter
  • Public and others
Promoter
51.00%
Public
49.00%
Promoter change
0.00 pp
Filed
12 Oct 2026
FII
2.39%
DII
1.77%
Promoter pledged
0.00%

Who the public is

Mutual funds
0.91%

+0.90 pp QoQ

Insurance
0.00%

0.00 pp QoQ

FPI
2.39%

-0.38 pp QoQ

Retail ≤ ₹2L
22.85%

+0.52 pp QoQ

HNI > ₹2L
9.07%

-1.22 pp QoQ

NRI
2.80%

+0.02 pp QoQ

Bodies corporate
7.47%

+0.71 pp QoQ

Shareholders
77,706

+3.5% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
PRESIDENT OF INDIAPromoter · Government26.00%
APOLLO HOSPITALS ENTERPRISE LIMITEDPromoter · Corporate22.02%
EMEDLIFE INSURANCE BROKING SERVICES LIMITEDCorporate1.70%
WEDGEWOOD HOLDINGS LIMITEDPromoter · Corporate1.61%
CITADEL RESEARCH AND SOLUTIONS LIMITEDCorporate1.29%
INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY MINISTRY OF CORPORATE AFFAIRSOther1.07%
PCR INVESTMENTS LIMITEDPromoter · Corporate0.42%
PRATAP C REDDYPromoter · Individual0.26%
PREETHA REDDYPromoter · Individual0.22%
SUCHARITHA P REDDYPromoter · Individual0.18%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 6 Sept 2012 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹4.00₹4.00
FY2025-261₹4.50₹4.50
FY2024-251₹4.50₹4.50
FY2023-241₹3.00₹3.00
FY2022-231₹2.50₹2.50
FY2019-201₹1.60₹1.60
FY2018-191₹1.50₹1.50
FY2017-181₹1.80₹1.80
FY2016-171₹1.80₹1.80
FY2015-161₹1.80₹1.80
FY2014-151₹1.80₹1.80
FY2013-141₹1.60₹1.60
FY2012-131₹1.60₹1.60
Ex-dateRecord dateDeclaredAdjusted
18 Sept 202618 Sept 2026₹4.00₹4.00
18 Sept 2025—₹4.50₹4.50
13 Sept 2024—₹4.50₹4.50
15 Sept 2023—₹3.00₹3.00
15 Sept 2022—₹2.50₹2.50
12 Sept 2019—₹1.60₹1.60
12 Sept 2018—₹1.50₹1.50
14 Sept 2017—₹1.80₹1.80
18 Aug 2016—₹1.80₹1.80
16 Sept 2015—₹1.80₹1.80
18 Sept 2014—₹1.80₹1.80
19 Sept 2013—₹1.60₹1.60
6 Sept 2012—₹1.60₹1.60

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Book closures & record dates

Loading…

NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.

Bulk & block deals · 8 Oct 2025

CSV
12 of 31 deals
By year
DateDealClientQuantityPriceValue
8 Oct 2025Buy · bulkGRAVITON RESEARCH CAPITAL LLP12.33L587.07₹72.4Cr
8 Oct 2025Sell · bulkGRAVITON RESEARCH CAPITAL LLP12.32L586.98₹72.3Cr
7 Oct 2025Buy · bulkSWAY FINANCIAL SERVICES4.88L555.26₹27.1Cr
7 Oct 2025Sell · bulkSWAY FINANCIAL SERVICES9.3K512.53₹47.6L
7 Aug 2024Sell · bulkGRAVITON RESEARCH CAPITAL LLP5.42L327.42₹17.7Cr
7 Aug 2024Buy · bulkGRAVITON RESEARCH CAPITAL LLP5.42L327.06₹17.7Cr
22 Apr 2024Buy · bulkQUANT MUTUAL FUND - QUANT SMALL CAP FUND5.50L249.59₹13.7Cr
9 Jun 2021Buy · bulkGRAVITON RESEARCH CAPITAL LLP7.08L99.69₹7.1Cr
9 Jun 2021Sell · bulkGRAVITON RESEARCH CAPITAL LLP7.08L99.69₹7.1Cr
7 Jun 2021Sell · bulkGRAVITON RESEARCH CAPITAL LLP4.84L96.56₹4.7Cr
7 Jun 2021Buy · bulkGRAVITON RESEARCH CAPITAL LLP4.84L96.45₹4.7Cr
19 May 2021Sell · bulkGRAVITON RESEARCH CAPITAL LLP6.09L90.97₹5.5Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to INDRAMEDCO.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

Standalone
₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations306.5314.7347.9349.8324.9333.8365.1381.0371.6364.8406.2412.9
Other income4.34.95.16.15.16.46.97.47.27.38.48.6
Total income310.7319.6353.0355.9330.1340.1372.0388.4378.8372.1414.6421.4
Total expenses270.1278.1293.4298.9285.5284.8303.7322.1322.4317.1339.8349.3
└ Finance costs0.91.61.61.61.61.51.61.51.51.51.71.7
└ Depreciation10.010.211.011.211.210.910.210.911.311.311.812.3
Profit before tax40.741.659.656.944.555.368.366.356.455.074.872.1
Tax expense11.210.414.814.511.714.316.916.915.413.319.018.5
Net profit29.431.244.842.432.841.051.549.541.041.755.953.6
EPS3.213.404.884.633.584.475.615.404.474.556.095.84
Net margin9.61%9.90%12.87%12.12%10.10%12.29%14.10%12.98%11.03%11.43%13.75%12.98%
PBT margin13.27%13.20%17.13%16.27%13.70%16.56%18.71%17.40%15.17%15.08%18.42%17.46%
Tax rate27.61%25.00%24.87%25.52%26.32%25.80%24.67%25.41%27.29%24.20%25.35%25.66%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 29 Oct 2026.

Balance sheet & cash flow · half-yearly

Standalone
₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets555.1667.6723.2806.3851.6954.1991.41,118.4
Current assets223.1302.5308.0419.7431.1594.1416.6513.4
└ Cash & equivalents52.338.161.666.861.52.64.96.5
└ Other bank balances76.5169.2162.8242.6260.3420.4258.4196.9
└ Current investments0.00.00.00.00.038.50.0142.2
└ Trade receivables68.268.458.475.175.599.0112.2131.6
└ Inventories8.58.07.57.97.07.67.97.9
Total equity379.5414.8477.8524.4596.7658.4740.4814.4
└ Attributable to owners379.5414.8477.8524.4596.7658.4740.4814.4
└ Share capital91.791.791.791.791.791.791.791.7
Borrowings0.00.00.00.00.00.00.00.0
└ Current0.00.00.00.00.00.00.00.0
└ Non-current0.00.00.00.00.00.00.00.0
Trade payables98.2135.8139.6132.5122.5117.3128.2129.7
Current liabilities129.6207.0165.4203.2178.7222.6169.6223.3
Total liabilities175.7252.8245.5281.9254.9295.8251.0304.0
Net debt(128.8)(207.3)(224.4)(309.4)(321.8)(461.4)(263.3)(345.5)
Debt / equity0.000.000.000.000.000.000.000.00
Current ratio1.721.461.862.072.412.672.462.30

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow144.5116.7200.278.5156.893.5167.4109.4
└ Capex(44.6)(35.6)(69.4)(20.3)(36.3)(12.7)(59.7)(32.6)
Free cash flow99.981.1130.858.2120.480.8107.876.8
Investing cash flow(107.9)(127.8)(158.4)(70.6)(111.0)(146.8)(177.6)(101.4)
Financing cash flow(26.0)(3.0)(32.4)(2.7)(45.9)(5.7)(46.4)(6.4)
└ Dividends paid(22.8)(0.0)(27.5)0.0(40.7)(2.8)(41.0)(2.6)
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash10.5(14.2)9.35.2(0.1)(58.9)(56.6)1.6

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

INDRAMEDCO at a glance

  • INDRAMEDCO closed at ₹362.6 on 20 Nov 2026, +0.62% on the day, -33.9% over one year, 34.4% below its 52-week high of ₹553.15.
  • Delivery was 40.7% of traded quantity on 20 Nov 2026, the 8th percentile of its own 3,629 sessions with a reading (20-session average 52.1%, 1-year average 54.9%).
  • Market capitalisation is ₹3,324 crore at a trailing P/E of 17.3 (trailing EPS ₹20.96).
  • Q2 FY27 results (standalone, filed 29 Oct 2026): revenue ₹413 crore (+8.4% year on year), net profit ₹54 crore (+8.3%); the price moved -4.0% on the first session after.
  • Promoters held 51.00% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 3 Feb 2027 and 9 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryHospital
ISININE681B01017
SeriesEQ
Listed17 Apr 1997
NSE market cap · 17 Nov 2026₹3,237 Cr
Free-float market cap (NSE)₹1,551 Cr
Shares outstanding (NSE)9.17Cr
History from7 May 1997
Sessions7,291
Turnover rank#847

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.